Sign In
Buy BHC
$4.95
-0.0600 (-1.20%)
At Close: Jun 03, 2026
Bausch Health To Participate At Goldman Sachs Annual Global Healthcare Conference
11:00am, Thursday, 21'st May 2020
Bausch Health Companies Inc. (NYSE/TSX: BHC) today announced that Joseph C. Papa, chairman and chief executive officer, and Arthur J. Shannon, senior vice president and head of Investor Relations and
Mario Gabelli Adds to Amazon Holding in 1st Quarter
09:27pm, Monday, 18'th May 2020
An overview of the guru's top 5 buys Continue reading...
Notable Insider Buys: Bausch, TransDigm And More
02:25pm, Sunday, 17'th May 2020
* Insider buying can be an encouraging signal for potential investors. * Directors stepped up to make sizable share purchases last week. * Some of those transactions came in the wake of earnings rep
LAVAL, Quebec , May 11, 2020 /CNW/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") announced today that it has priced and upsized its previously announced offerin
Bausch Health launches offering of $1.25 billion in senior notes that mature in 2029
11:19am, Monday, 11'th May 2020
Bausch Health Cos. Inc. , the company formerly known as Valeant, said Monday it has launched an offering of $1.25 billion of new senior notes that mature in 2029. Proceeds will be used to fund the red
Bausch Health Announces Launch of Private Offering of Senior Notes and Conditional Redemption of Existing Senior Secured Notes
11:08am, Monday, 11'th May 2020
Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") announced today that it has launched an offering of $1,250,000,000 aggregate principal amount of new senior notes due 20
Bausch Health Companies Inc. (BHC) Q1 2020 Earnings Call Transcript
05:30pm, Saturday, 09'th May 2020
Participating on today's call are Chairman and Chief Executive Officer, Mr. Joe Papa; and Chief Financial Officer, Mr. Paul Herendeen. In addition to this live webcast, a copy of today's slide presen
Bausch (BHC) Down on Q1 Earnings & Sales Miss, View Trimmed
10:43pm, Friday, 08'th May 2020
Bausch (BHC) misses on earnings and sales in the first quarter and lowers guidance due to the coronavirus pandemic.
Biotech Funds Could Rally to New Highs
03:05pm, Friday, 08'th May 2020
Biotech funds have rallied within striking distance of multi-year resistance and could break out in coming weeks.
Endo (ENDP) Q1 Earnings Beat on Coronavirus-Led Stockpiling
02:26pm, Friday, 08'th May 2020
Endo's (ENDP) earnings and sales beat estimates in the first quarter owing to increased customer inventory purchasing due to the COVID-19 pandemic
Coronavirus update: U.S. death toll tops 74,000, as Trump administration shelves ‘too cautious’ CDC guide to reopening
07:17pm, Thursday, 07'th May 2020
The number of U.S. fatalities from the coronavirus that causes COVID-19 climbed above 73,000 on Thursday, as President Donald Trump’s administration said it is shelving recommendations from the Cent
Erytech Spikes On Fast Track, And Other News: The Good, Bad And Ugly Of Biopharma
04:08pm, Friday, 01'st May 2020
Erytech spiked 37% after lead pancreatic cancer drug candidate fast tracked by the FDA. Pfizer is progressing with its Covid-19 treatment candidate. Bausch Heal
Largest borrow rate increases among liquid names AAL;SPCE;APHA;NEPT;MTCH;CODX;MJ;DKNG;BHC
01:15pm, Tuesday, 28'th Apr 2020
Largest borrow rate increases among liquid names AAL SPCE APHA NEPT MTCH CODX MJ DKNG BHC
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Zimmer Biomet Holdings (ZBH), Bausch Health Companies
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Zimmer Biomet Holdings
